Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Double-blind randomized controlled trial to evaluate the serum levels of 25(OH)D after a
single oral dose of cholecalciferol 50,000 IU plus ezetimibe or placebo.
Differences between the serum levels of 25(OH)D in response to cholecalciferol plus ezetimibe
compared to cholecalciferol plus placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Federal University of Rio Grande do Sul
Treatments:
Cholecalciferol Ergocalciferols Ezetimibe Vitamin D Vitamins